AKT1 and Alzheimer disease: Although AD patients tend to be physiologically overall insulin resistant, evidence also suggests that the level of insulin/insulin signaling is unchanged or increased in AD brains12, and downstream activity like AKT (also known as PKB, protein kinase B) is upregulated13,14.